| Literature DB >> 26515769 |
Zewdie Mulissa Deksissa1, Fessahaye Alemseged Tesfamichael2, Henok Assefa Ferede3.
Abstract
BACKGROUND: Cervical cancer is the 2nd most frequent and top killer cancer among women in Ethiopia. Prevalence and factors associated with visual inspection with acetic acid (VIA) positive result is not studied yet at the study area.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26515769 PMCID: PMC4627428 DOI: 10.1186/s13104-015-1594-x
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Baseline characteristics of clients screened using VIA at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, 2013
| Characteristics | Number (%) |
|---|---|
| Age in years | |
| 25–30 | 172 (51.5) |
| 31–35 | 79 (23.7) |
| 36–40 | 61 (18.3) |
| 41–45 | 22 (6.6) |
| Educational status | |
| Illiterate | 73 (21.9) |
| Primary | 105 (31.4) |
| Secondary | 105 (31.4) |
| Tertiary | 51 (15.3) |
| Marital status | |
| Single | 11 (21.9) |
| Married | 246 (73.7) |
| Divorced | 38 (11.4) |
| Widowed | 23 (6.9) |
| Separated | 16 (4.8) |
| Parity | |
| Nulliparous | 31 (9.3) |
| Primiparous | 72 (21.6) |
| Multiparous | 231 (69.2) |
| Age at first intercourse | |
| <16 | 148 (44.3) |
| 16 | 175 (52.4) |
| Unknown | 11 (3.3) |
| Current contraceptive | |
| OCP | 20 (6) |
| DEPO | 57 (17.1) |
| Implanon | 9 (2.7) |
| Jadelle | 6 (1.8) |
| IUCD | 6 (1.8) |
| Condom | 7 (2.1) |
| BTL | 2 (0.6) |
| Dual contraception | 8 (1.5) |
| None | 222 (66.5) |
| STI history | |
| Yes | 51 (15.3) |
| No | 283 (84.7) |
| HIV sero-status | |
| Unknown | 28 (8.4) |
| Negative | 171 (51.2) |
| Positive | 135 (40.4) |
| HIV positives | |
| On HAART | 110 (81.5) |
| Not on HAART | 25 (18.5) |
| N | |
| One | 244 (73.1) |
| Multiple | 90 (26.9) |
| Yes | 334 (100) |
| SCJ seen | |
| No | 0 |
VIA test result, cryotherapy eligibility and reasons for referral among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, 2013
| Characteristics | Number (%) |
|---|---|
| VIA test result | |
| Positive | 43 (12.9) |
| Negative | 287 (85.9) |
| Suspicious for cancer | 4 (1.2) |
| Cryotherapy eligibility | |
| Eligible | 42 (97.7) |
| Ineligible | 1 (2.3) |
| Reasons for referral | |
| Suspicious for cancer | 4 (80) |
| Lesion larger than cryoprobe >2 mm | 1 (20) |
Fig. 1Profile of clients screened using VIA at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, 2013. Three hundred and thirty-four clients were screened using VIA at Jimma model clinic. Age at onset of intercourse and HIV-status were unknown in 11 and 28 screened clients respectively while both age at onset of intercourse and HIV-status were unknown in 3 resulting in exclusion of a total of 36 screened clients from logistic regression analysis. Thus, only 298 were eligible for logistic regression analysis
Logistic regression analysis of factors associated with VIA positive at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, 2013
| Covariates | VIA result | |||
|---|---|---|---|---|
| Positive, no. (%) | Negative, no. (%) | COR [95 % CI] | AOR [95 % CI] | |
| Age | ||||
| 25–30 | 30 (17.8) | 139 (82.2) | 1 | 1 |
| 31–35 | 8 (10.1) | 71 (89.9) | 0.5 [0.2, 1.1] | 0.5 [0.2, 1.2] |
| 36–40 | 3 (5) | 57 (95) | 0.3 [0.1, 0.9]* | 0.4 [0.1, 1.1] |
| 41–45 | 2 (9.1) | 20 (90.9) | 0.4 [0.1, 1.9] | 0.5 [0.1, 2.3] |
| Age at first intercourse | ||||
| 16 years | 17 (9.7) | 158 (90.3) | 1 | 1 |
| <16 years | 22 (15.3) | 122 (84.7) | 2 [1.1, 4.0]* | 2.2 [1.1, 4.3]* |
| Current use contraceptive | ||||
| No | 25 (11.4) | 194 (88.6) | 1 | 1 |
| Yes | 18 (16.2) | 93 (83.8) | 1.4 [0.8, 2.7] | 1.7 [0.9, 3.3] |
| History of STI | ||||
| No | 35 (12.5) | 245 (87.5) | 1 | 1 |
| Yes | 8 (16) | 42 (84) | 1.3 [0.6, 3.1] | 1.6 [0.7, 3.6] |
| Number of sexual partners | ||||
| One | 32 (13.3) | 209 (86.7) | 1 | 1 |
| Multiple | 11 (12.4) | 78 (87.6) | 0.9 [0.5, 2.9] | 0.7 [0.3, 1.6] |
| HIV sero-status | ||||
| Negative | 20 (11.9) | 148 (88.1) | 1 | 1 |
| Positive | 21 (15.7) | 113 (84.3) | 0.8 [0.4, 1.5] | 1.2 [0.6, 2.6] |
| HIV positives | ||||
| Not on HAART | 2 (8.3) | 22 (91.7) | 1 | 1 |
| On HAART | 19 (17.3) | 91 (82.7) | 0.7 [0.2, 2.4] | 0.7 [0.2, 2.6] |